Continental Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,000
Closed -$287K 105
2017
Q3
$287K Sell
20,000
-73,200
-79% -$1.11M 0.07% 113
2017
Q2
$1.61M Buy
93,200
+22,200
+31% +$266K 0.36% 78
2017
Q1
$783K Sell
71,000
-20,000
-22% -$275K 0.18% 108
2016
Q4
$1.32M Buy
91,000
+74,000
+435% +$1.36M 0.36% 84
2016
Q3
$417K Hold
17,000
0.12% 128
2016
Q2
$342K Buy
+17,000
New +$481K 0.11% 112

Other funds holding BHC

Continental Advisors's BHC Position: Q2 2022 in Review

Continental Advisors sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 23,000 shares — an estimated $526K sold.

Continental Advisors first reported a position in BHC in Q1 2016 and held it in 25 quarters. The position peaked at $4.07M in Q3 2018. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Continental Advisors reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Continental Advisors sold 23,000 Bausch Health shares in Q2 2022, an estimated $526K.
  • Continental Advisors first reported a position in Bausch Health in Q1 2016 and held it in 25 quarters.
  • Continental Advisors's Bausch Health position peaked at $4.07M in Q3 2018.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Continental Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.